drugset / Trial / NCT01253824

Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers

NCT01253824

Phase 3 Completed 14 enrolled Nobelpharma
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the serum levels of estradiol, progesterone, FSH and LH in NPC-01 or IKH-01 one treatment cycle with those in before and after administration cycle.

Timeline

Start
2011-01
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator ethinyl estradiol Small molecule 0.02 mg
Comparator ethinyl estradiol Small molecule 0.035 mg
Comparator ethinyl estradiol Small molecule 0.35 mg
Comparator Norethindrone Unknown 1 mg

Indications

No indication recorded.